Need a specific person's email?
Browse Rgenta Therapeutics Inc.'s employee directory (about 33 employees) and reveal verified emails free.
Rgenta Therapeutics Inc.'s most common email format is First.Last@rgentatx.com (ex. John.Doe@rgentatx.com), used for 96% of rgentatx.com addresses. Rgenta Therapeutics Inc. uses 2 email patterns.
| Format | Example | Share of rgentatx.com |
|---|---|---|
| First.Last@rgentatx.comMost common | John.Doe@rgentatx.com | |
| First.Middle@rgentatx.com | John.Michael@rgentatx.com |
Browse Rgenta Therapeutics Inc.'s employee directory (about 33 employees) and reveal verified emails free.
Biotechnology ResearchMassachusetts, United States11-50 Employees
Rgenta Therapeutics is a small biotechnology company developing oral, small-molecule medicines that target RNA processing events. Its focus spans oncology and neurological disorders, aiming to address diseases driven by RNA regulation that have been difficult to treat. The company relies on a proprietary platform to identify actionable RNA processing events and to design small molecules that influence the interactions among spliceosome components, regulatory proteins, and RNAs. Headquartered in Woburn, Massachusetts, the firm is building a pipeline led by RGT-61159. In 2026, it reported positive preliminary data from ongoing Phase 1a/b trials of RGT-61159 in Adenoid Cystic Carcinoma and Colorectal Cancer, disclosed at ASCO.
Most common format
First.Last@rgentatx.com
Example: John.Doe@rgentatx.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.